China Pharma E-Commerce Set For Tighter Regulation As Models Shift
This article was originally published in PharmAsia News
Executive Summary
China is set to formulate more policies and standards for its booming pharmaceutical e-commence sector after the issuance of draft supervision and administration of online drug business operations last year. Prescription drugs and health insurance systems are the biggest obstacles that need to be faced.